Discovery at MIDD Leads to Human Trials

For the first time, a compound discovered at the Milwaukee Institute for Drug Discovery, or MIDD, has been approved to enter human clinical trials. The drug is under development by Damona Pharmaceuticals, a biopharmaceutical company developing drugs to reverse cognitive deficits associated with brain disorders. It’s the first step of testing the drug in humans […]